UK Stocks Edge Lower as AstraZeneca Plunge Offsets Broader Gains

The United Kingdom's main stock index closed slightly lower on Monday, as significant declines in large-cap healthcare and consumer staples companies outweighed gains across the broader market. According to data from Investing.com, the Investing.com United Kingdom 100 index fell by 0.17% by the end of the trading session.

Sector Performance and Key Movers

The decline was primarily driven by weakness in the Pharmaceuticals & Biotech, Tobacco, and Fixed Line Telecommunications sectors. A steep drop in pharmaceutical giant AstraZeneca PLC (LON:AZN), which plunged 8.79%, was the single largest drag on the index.

Other notable decliners among blue-chip stocks included:

• Coca Cola HBC AG (LON:CCH), which fell 2.52%.
• British American Tobacco PLC (LON:BATS), down 2.28%.

Broader Market Shows Underlying Strength

Ad

Despite the headline index's negative close, market breadth on the London Stock Exchange was positive, indicating strength in other parts of the market. Rising stocks outnumbered declining ones by a significant margin, with 1,095 companies advancing compared to 604 that fell, while 554 ended the session unchanged.

Leading the gainers on the benchmark index were homebuilder Vistry Group PLC (LON:VTYV), which surged 7.95%, and Barratt Redrow PLC (LON:BTRW), which added 3.82%. Pest control firm Rentokil Initial PLC (LON:RTO) also posted a strong performance, rising 3.48%.

Commodities and Currencies

In the wider financial markets, commodity prices saw significant downward pressure. Crude oil for September delivery fell sharply by 5.91% to $79.67 a barrel, while the October Brent contract dropped 4.75% to $83.75 a barrel. Gold futures for December delivery were also down, slipping 0.39%.

In currency markets, the British pound weakened against the U.S. dollar, with the GBP/USD pair falling 0.38% to 1.34. Meanwhile, the U.S. Dollar Index Futures ticked up 0.05%, reflecting modest strength in the greenback.